Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma-Reference-Cited by-同舟云学术

Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma

Published:2020-05-14 Issue:1 Volume:20 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Chen Peng,Jiao Liang,Ren Fang,Wang Dan-Bo

Funder

National Natural Science Foundation of China

Shengjing Hospital of China Medical University

Natural Science Foundation of Liaoning Province

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-020-06934-x.pdf

Reference37 articles.

1. Tanderup K, Fokdal LU, Sturdza A, Haiemeder C, Mazeron R, Van LE, et al. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer. Radiother Oncol. 2016;120(3):441–6.

2. Caffarel MM, Coleman N. Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma. J Pathol. 2014;232(4):386–90.

3. Sturgeon C, Duffy M, Hofmann B, Lamerz R, Fritsche H, Gaarenstroom K, et al. National Academy of Clinical Biochemistry Laboratory medicine practice guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Clin Chem. 2010;56(6):e1–48.

4. Qin T, Zhen J, Zhou M, Wu H, Rui R, Bo Q, et al. Efficacy of neoadjuvant chemotherapy plus radical surgery in patients with bulky stage II cervical squamous cell carcinoma: a retrospective cohort study. Int J Surg. 2016;30:121–5.

5. Hu T, Li S, Chen Y, Shen J, Li X, Huang K, et al. Matched-case comparison of neoadjuvant chemotherapy in patients with FIGO stage IB1-IIB cervical cancer to establish selection criteria. Eur J Cancer. 2012;48(15):2353–60.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Significance of Serum SCC Levels Before Treatment for Locally Advanced Cervical Squamous Cell Carcinoma;Anticancer Research;2024-04-27

2. Deciphering the potential of proteomic-based biomarkers in women’s reproductive diseases: empowering precision medicine in gynecology;Biomarkers;2024-01-02

3. TNF-α-induced down-regulation of type I interferon receptor contributes to acquired resistance of cervical squamous cancer to Cisplatin;The Journal of Antibiotics;2023-12-15

4. Diagnostic Efficacy of Serum Squamous Cell Carcinoma Antigen for Cancerous and Noncancerous Diseases: A Single-Center Experience in China;J BIOL REG HOMEOS AG;2023

5. Elevated pretreatment squamous cell Carcinoma Antigen indicates unfavorable treatment outcomes in cervical cancer patients receiving definitive radiotherapy;Precision Radiation Oncology;2023-07-16